Ongini E - Search Results

1

Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury.

Briscini L, Corradini L, Ongini E, Bertorelli R. Briscini L, et al. Among authors: ongini e. Eur J Pharmacol. 2002 Jun 28;447(1):59-65. doi: 10.1016/s0014-2999(02)01833-2. Eur J Pharmacol. 2002. PMID: 12106803

2

Lack of the nociceptin receptor does not affect acute or chronic nociception in mice.

Bertorelli R, Bastia E, Citterio F, Corradini L, Forlani A, Ongini E. Bertorelli R, et al. Among authors: ongini e. Peptides. 2002 Sep;23(9):1589-96. doi: 10.1016/s0196-9781(02)00102-x. Peptides. 2002. PMID: 12217419

3

Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages.

Ronchetti D, Impagnatiello F, Guzzetta M, Gasparini L, Borgatti M, Gambari R, Ongini E. Ronchetti D, et al. Among authors: ongini e. Eur J Pharmacol. 2006 Feb 17;532(1-2):162-9. doi: 10.1016/j.ejphar.2005.12.034. Epub 2006 Jan 27. Eur J Pharmacol. 2006. PMID: 16443213

4

A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Wu WP, Hao JX, Ongini E, Impagnatiello F, Presotto C, Wiesenfeld-Hallin Z, Xu XJ. Wu WP, et al. Among authors: ongini e. Br J Pharmacol. 2004 Jan;141(1):65-74. doi: 10.1038/sj.bjp.0705596. Epub 2003 Dec 8. Br J Pharmacol. 2004. PMID: 14662726 Free PMC article.

5

Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain.

Bertorelli R, Corradini L, Rafiq K, Tupper J, Calò G, Ongini E. Bertorelli R, et al. Among authors: ongini e. Br J Pharmacol. 1999 Nov;128(6):1252-8. doi: 10.1038/sj.bjp.0702884. Br J Pharmacol. 1999. PMID: 10578139 Free PMC article.

6

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.

Ongini E, Dionisotti S, Gessi S, Irenius E, Fredholm BB. Ongini E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1999 Jan;359(1):7-10. doi: 10.1007/pl00005326. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 9933143

7

Nociceptin/orpanin FQ and its receptor: a potential target for drug discovery.

Bertorelli R, Calò G, Ongini E, Regoli D. Bertorelli R, et al. Among authors: ongini e. Trends Pharmacol Sci. 2000 Jul;21(7):233-4. doi: 10.1016/s0165-6147(00)01492-9. Trends Pharmacol Sci. 2000. PMID: 10979861 No abstract available.

8

Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain.

Taglialatela M, Ongini E, Brown AM, Di Renzo G, Annunziato L. Taglialatela M, et al. Among authors: ongini e. Eur J Pharmacol. 1996 Dec 5;316(2-3):373-7. doi: 10.1016/s0014-2999(96)00802-3. Eur J Pharmacol. 1996. PMID: 8982710

9

Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist.

Domenici MR, Sagratella S, Ongini E, Longo R, Scotti de Carolis A. Domenici MR, et al. Among authors: ongini e. Eur J Pharmacol. 1994 Dec 27;271(2-3):259-63. doi: 10.1016/0014-2999(94)90782-x. Eur J Pharmacol. 1994. PMID: 7705426

10

In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit.

Sandoli D, Chiu PJ, Chintala M, Dionisotti S, Ongini E. Sandoli D, et al. Among authors: ongini e. Eur J Pharmacol. 1994 Jun 23;259(1):43-9. doi: 10.1016/0014-2999(94)90155-4. Eur J Pharmacol. 1994. PMID: 7957592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results